Mizoribine provides effective treatment of sequential histological change of arteritis and reduction of inflammatory cytokines and chemokines in an animal model of Kawasaki disease

<p>Abstract</p> <p>Background</p> <p>Intravenous immunoglobulin (IVIg) treatment results in an effective response from patients with acute-phase Kawasaki disease (KD), but 16.5% of them remain nonresponsive to IVIg. To address this therapeutic challenge, we tried a new...

Full description

Bibliographic Details
Main Authors: Ohno Naohito, Nagi-Miura Noriko, Yamada Hitomi, Yokouchi Yuki, Nagao Tomokazu, Oharaseki Toshiaki, Takahashi Kei, Saji Tsutomu, Okazaki Tomio, Suzuki Kazuo
Format: Article
Language:English
Published: BMC 2011-09-01
Series:Pediatric Rheumatology Online Journal
Subjects:
Online Access:http://www.ped-rheum.com/content/9/1/30